Impact of SARS-CoV-2 Pandemic on Patients with Primary Immunodeficiency.
J Clin Immunol
; 41(2): 345-355, 2021 02.
Article
in English
| MEDLINE | ID: covidwho-954575
ABSTRACT
Although it is estimated that COVID-19 life-threatening conditions may be diagnosed in less than 11000 infected individuals below the age of 50, but the real impact of this pandemic on pediatric patients with different types of primary immunodeficiency (PID) is not elucidated. The current prospective study on a national registry of PID patients showed that with only 1.23 folds higher incidence of infections, these patients present a 10-folds higher mortality rate compared to population mainly in patients with combined immunodeficiency and immune dysregulation. Therefore, further management modalities against COVID-19 should be considered to improve the survival rate in these two PID entities using hematopoietic stem cell transplantation and immunomodulatory agents.
Keywords
Full text:
Available
Collection:
International databases
Database:
MEDLINE
Main subject:
Health Impact Assessment
/
Primary Immunodeficiency Diseases
/
SARS-CoV-2
/
COVID-19
Type of study:
Cohort study
/
Diagnostic study
/
Experimental Studies
/
Observational study
/
Prognostic study
Topics:
Long Covid
Limits:
Child, preschool
/
Female
/
Humans
/
Infant
/
Male
Language:
English
Journal:
J Clin Immunol
Year:
2021
Document Type:
Article
Affiliation country:
S10875-020-00928-x
Similar
MEDLINE
...
LILACS
LIS